IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

IGC Pharma Inc (IGC)

CUSIP: 45408X308 | NYSE | Healthcare · Biotechnology | Micro Cap | 129 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Geode Capital Management, LLC1,041,137
0.0% of portfolio›$280.0K
Lawood & Co75,000
0.0% of portfolio›$20.2K
Fisher Asset Management, LLC43,400
0.0% of portfolio›$11.7K
Truist Financial Corp36,667
0.0% of portfolio›$9.9K
Schneider Downs Wealth Management Advisors, LP30,000
0.0% of portfolio›$8.1K
Wealthcare Advisory Partners LLC10,000
0.0% of portfolio›$2.7K
Farther Finance Advisors, LLC110
0.0% of portfolio›$30
Hurley Capital, LLC100
0.0% of portfolio›$27
Barclays PLC4
0.0% of portfolio›$1
Triumph Capital Management2
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Geode Capital Management, LLC
1,041,137$280.0K0.0%IndexVery LowBoston, MA2026-11-06
Lawood & Co
75,000$20.2K0.0%CoreLowWilliamsport, PA2026-10-09
Fisher Asset Management, LLC
43,400$11.7K0.0%CoreLowPlano, TX2026-11-06
Truist Financial Corp
36,667$9.9K0.0%CoreLowCharlotte, NC2026-10-30
Schneider Downs Wealth Management Advisors, LP
30,000$8.1K0.0%ETFVery LowPittsburgh, PA2026-10-27
Wealthcare Advisory Partners LLC
10,000$2.7K0.0%ETFLowWest Chester, PA2026-10-21
Farther Finance Advisors, LLC
110$300.0%IndexLowSan Francisco, CA2026-10-08
Hurley Capital, LLC
100$270.0%GARPMediumNew York, NY2026-11-05
Barclays PLC
4$10.0%CoreMediumLondon, United Kingdom2026-11-06
Triumph Capital Management
2$10.0%ETFMediumDenver, CO2026-10-14